← Back to Search

Behavioural Intervention

Therapy arm for Snoring

N/A
Waitlist Available
Research Sponsored by Signifier Medical Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between pre-therapy (day 7) and post therapy (day 49)
Awards & highlights

Study Summary

This trial will help to improve our understanding of how the eXciteOSA device affects snoring and sleep apnoea and will provide valuable information on whether this new device is an effective treatment for these conditions.

Eligible Conditions
  • Snoring
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between pre-therapy (day 7) and post therapy (day 49)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between pre-therapy (day 7) and post therapy (day 49) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Snoring
Change in sleep disordered breathing indices - Apnea Hypopnea Index (AHI)
Change in sleep disordered breathing indices - Oxygen Desaturation Index (ODI)
Secondary outcome measures
Comparison of quality of life questionnaires at start and end of therapy - EQ-5D-5L
Comparison of sleep quality questionnaires at start and end of therapy - Epsworth Sleepiness Score (ESS)
Comparison of sleep quality questionnaires at start and end of therapy - Pittsburgh Sleep Quality Index (PSQI)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Therapy armExperimental Treatment1 Intervention
Six week use of eXciteOSA device. Once daily for 20 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eXciteOSA
2022
N/A
~110

Find a Location

Who is running the clinical trial?

Signifier Medical TechnologiesLead Sponsor
3 Previous Clinical Trials
279 Total Patients Enrolled
1 Trials studying Snoring
115 Patients Enrolled for Snoring
Jessie P Bakker, PhDStudy DirectorSignifier Medical Technologies
2 Previous Clinical Trials
164 Total Patients Enrolled
Yasser ZayniStudy DirectorSignifier Medical Technologies
2 Previous Clinical Trials
164 Total Patients Enrolled

Media Library

eXciteOSA (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04392765 — N/A
Snoring Research Study Groups: Therapy arm
Snoring Clinical Trial 2023: eXciteOSA Highlights & Side Effects. Trial Name: NCT04392765 — N/A
eXciteOSA (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04392765 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new enrollees accepted into this experiment?

"Contrary to popular belief, this clinical trial is not presently recruiting patients. Initially posted on May 11th 2020 and last updated in December 1st 2022, the study has yet to begin enrollment. However, there are 293 other studies actively enrolling participants at this time."

Answered by AI

What aims does this experiment seek to achieve?

"This investigation intends to measure the impact of pre-therapy and post-therapy conditions on Apnea Hypopnea Index (AHI). Secondary goals include comparing sleep quality questionnaires with Pittsburgh Sleep Quality Index (PSQI) and Epsworth Sleepiness Score (ESS), as well as assessing snoring levels via a visual analogue scale reported by their sleeping partner."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
OLVG, Amsterdam
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
~41 spots leftby Apr 2025